
Brian Gossett
Founder & Biotechnology Research Industry Entrepreneur
Brian Gossett is an entrepreneur with more than 20 years of experience building and operating businesses in diverse sectors. His portfolio has a strong focus on biotechnology and research products. He is the founder of several research companies and has worked extensively with research compounds, analytical testing, laboratory suppliers, research institutions, and the evolving peptide research industry.
His writing for Peptide Basics focuses on peptide research, industry developments, laboratory quality, emerging compounds, and translating complex research topics into accessible educational content.
Disclosure: Brian is the founder of Base Peptides, a large research peptide supplier. Peptide Basics articles are educational in nature, and commercial relationships relevant to an article are disclosed where appropriate.
Use of AI: Peptide Basics uses artificial intelligence tools to assist with research organization, source discovery, and drafting. Published articles are directed, reviewed, and edited by Brian Gossett or the identified author. AI-generated material is not used as a primary source. Scientific and regulatory claims are supported by cited underlying sources and thoroughly reviewed by human staff for accuracy and editing.
Content is educational and is not medical advice or medical care. See our editorial standards, about page, or contact us to report an error.
Coverage areas
Recent articles
- Clinical Trials · Retatrutide Phase 3 Results: Weight Loss, Knee Pain, and Sleep Apnea
- Regulatory · FDA Updates the Path for Generic Peptide Drugs
- Industry · Peter Attia on Peptides: His Framework, the Evidence, and the Open Questions
- Drug Delivery · A Once-Weekly Oral Peptide Enters Human Testing
- Clinical Trials · Redasemtide: What Two Trials Reveal About Regenerative Peptide Research
- Regulatory · What FDA's Latest Peptide Warning Letter Actually Says
- Industry · Andrew Huberman on Peptides and the Future of Consumer Health
- Industry · Where to Start With TRT: Testing, Benefits & Online Treatment Options
- Industry · Women’s Hormone Health: Menopause Therapy, Testing & Online Care
- Industry · Ways2Well: Services, Patient Control, Potential & Alternatives
- Industry · Peptides Discussed on Modern Wisdom’s Biohacking Roundtable #1148
- Industry · Peptides Mentioned by Brigham Buhler on Joe Rogan Experience #2469
- Industry · Peptides Mentioned by Andrew Huberman on Huberman Lab
- Lab & Quality · Why Is My Peptide Gelling? Signs BAC Water or a Reconstituted Vial May Be Compromised
- Regulatory · FDA Expands Mounjaro to Reduce Cardiovascular Risk: What SURPASS-CVOT Actually Showed
- Regulatory · FDA Approves Mimrylo (Rusfertide): A Hepcidin-Mimetic Peptide for Polycythemia Vera
- Regulatory · FDA Peptide Approvals and Rejections: What the July 23–24, 2026 Government Meeting Decided
- Biotechnology · Pioneers and Innovators of Peptide Science and Research
- Lab & Quality · Why the Reconstitution Liquid You Choose Actually Matters
- Clinical Trials · Peptide Clinical Trial Watch 2026: Beyond Weight Loss
- Drug Delivery · Why Long-Acting Peptides Are Becoming a Pharmaceutical Priority
- Drug Delivery · Nasal Peptides Are Expanding: Delivery Straight Toward the Brain
- Lab & Quality · The Race to Replace Injectable Peptides
- Drug Discovery · Macrocyclic Peptides Are Expanding Drug Discovery
